These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 6147191
1. Sarcolemmal alterations during the development of genetically determined cardiomyopathy. Panagia V, Singh JN, Anand-Srivastava MB, Pierce GN, Jasmin G, Dhalla NS. Cardiovasc Res; 1984 Sep; 18(9):567-72. PubMed ID: 6147191 [Abstract] [Full Text] [Related]
10. Role of membrane integrity and cation interaction for heart sarcolemmal adenylate cyclase and Na+-K+ ATPase. Chauhan MS, Anand-Srivastava MB, Panagia V, Dhalla NS. Adv Myocardiol; 1982 Sep; 3():317-27. PubMed ID: 6302775 [Abstract] [Full Text] [Related]
11. Sarcolemmal Na+-Ca2+ exchange and Ca2+-pump activities in cardiomyopathies due to intracellular Ca2+-overload. Dhalla NS, Panagia V, Makino N, Beamish RE. Mol Cell Biochem; 1988 Sep; 82(1-2):75-9. PubMed ID: 2972915 [Abstract] [Full Text] [Related]
12. Defective membrane systems in dystrophic skeletal muscle of the UM-X7.1 strain of genetically myopathic hamster. Dhalla NS, Singh A, Lee SL, Anand MB, Bernatsky AM, Jasmin G. Clin Sci Mol Med; 1975 Oct; 49(4):359-68. PubMed ID: 127686 [Abstract] [Full Text] [Related]
13. Multiple cardiac contractile protein abnormalities in myopathic Syrian hamsters (BIO 53 : 58). Malhotra A, Karell M, Scheuer J. J Mol Cell Cardiol; 1985 Feb; 17(2):95-107. PubMed ID: 3158746 [Abstract] [Full Text] [Related]
14. Changes in the expression of cardiac Na+-K+ ATPase subunits in the UM-X7.1 cardiomyopathic hamster. Kato K, Lukas A, Chapman DC, Dhalla NS. Life Sci; 2000 Feb; 67(10):1175-83. PubMed ID: 10954051 [Abstract] [Full Text] [Related]
15. Exaprolol as a modulator of heart sarcolemmal (Na+ + K+)-ATPase. Evidence for interaction with an essential sulfhydryl group in the catalytic centre of the enzyme. Dzurba A, Ziegelhöffer A, Schmidtová L, Breier A, Vrbjar N, Okolicány J. Gen Physiol Biophys; 1985 Jun; 4(3):257-64. PubMed ID: 2863195 [Abstract] [Full Text] [Related]
16. Role of sarcolemmal changes in cardiac pathophysiology. Dhalla NS, Tomlinson CW, Singh JN, Lee SL, McNamara DB, Harrow JA, Yates JC. Recent Adv Stud Cardiac Struct Metab; 1976 Jun; 9():377-94. PubMed ID: 130663 [Abstract] [Full Text] [Related]
17. Two site binding of bepridil and modulation of adenylate cyclase in cardiac sarcolemmal membranes. Cramb G, Dow JW. Biochim Biophys Acta; 1983 Dec 07; 736(1):99-108. PubMed ID: 6317030 [Abstract] [Full Text] [Related]
18. Influence of myosin antiserum on heart sarcolemmal Ca2+ or Mg2+ ATPase activity. Tuana BS, Kutryk MJ, Elimban V, Wikman-Coffelt J, Dhalla NS. Res Commun Chem Pathol Pharmacol; 1984 Aug 07; 45(2):297-300. PubMed ID: 6148777 [Abstract] [Full Text] [Related]
19. Ca2+- and Mg2+-dependent ATPase activities in the deoxycholate-treated rat heart sarcolemma. Panagia V, Lamers JM, Singal PK, Dhalla NS. Int J Biochem; 1982 Aug 07; 14(5):387-97. PubMed ID: 6123455 [Abstract] [Full Text] [Related]
20. Effect of prostaglandins on rat heart sarcolemmal ATPases. Karmazyn M, Tuana BS, Dhalla NS. Can J Physiol Pharmacol; 1981 Nov 07; 59(11):1122-7. PubMed ID: 6119148 [Abstract] [Full Text] [Related] Page: [Next] [New Search]